Deal consolidates firms’ technology in molecular diagnostics. Qiagen and Digene entered into a definitive agreement to combine the two companies to create market and technology leadership in molecular ...
-- Digene shareholders who tendered Digene shares in the exchange offer and elected to receive cash consideration or did not make an election in respect of those shares, representing approximately ...
NEW YORK, June 3 (Reuters) - Qiagen NV , a maker of genetic testing equipment, said on Sunday it will acquire Digene Corp. for $1.6 billion in cash and stock, to expand into testing for cervical ...
LONDON (MarketWatch) -- Digene Corp. said that it has signed a settlement and license deal with Georgetown University over patent litigation. Digene will record a pretax charge of $7.5 million in ...
What: Daryl Faulkner, Chief Executive Officer of Digene Corporation (DIGE), will preside over the opening bell in honor of "Cervical Cancer Screening Month." Where: NASDAQ MarketSite - 4 Times Square ...
GAITHERSBURG, Md., Jan. 11, 2008 -- QIAGEN Gaithersburg Inc. (formerly Digene Corporation), a wholly owned subsidiary of QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) today announced that it was granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results